Making Waves

AINOSTICS news and updates

AINOSTICS

AINOSTICS recognised as one of the UK's leading AI scaleups

We’re delighted to announce that AINOSTICS has been selected for the TechNation Applied AI 3.0 programme, joining a network of the UK’s...

AINOSTICS

Meet our summer interns

We are excited to welcome three very bright students from the University of Manchester who will be spending the summer with us at...

AINOSTICS

AINOSTICS welcomes Dr Michele Guerreri

AINOSTICS would like to announce that as part of an UKRI funded Innovation Scholars Secondments in Biomedical Sciences, Dr Michele...

AINOSTICS

AINOSTICS named as one of the best science and engineering companies in Manchester, UK.

We are honoured to have been named by engineeringness.com as one of the top science and engineering companies in Manchester, UK. The...

AINOSTICS

Our CEO speaking at MedTech Integrates 2021

Join our CEO Dr Hojjat Azadbakht who will be taking part in a panel discussion at this year’s MedTech Integrates entitled ‘Prediction is...

AINOSTICS

Losing Clive to Younger Onset Dementia: One Family's Story. A book by our very own Dr Helen Beaumont

Losing Clive to Younger Onset Dementia: One Family's Story, is a book published by Dr Helen Beaumont, Imaging Scientist at AINOSTICS,...

AINOSTICS

Bionow Start Up of the Year Award

We are thrilled to be shortlisted for the Bionow Start Up of the Year Award, as part of the Bionow Awards 2020, Showcasing the best of...

AINOSTICS

AINOSTICS accepted into the NVIDIA INCEPTION program

AINOSTICS was today accepted into the NVIDIA Inception program. The program nurtures cutting-edge AI startups that are revolutionising...

AINOSTICS

And the winner is ... AINOSTICS

It is with great pleasure to announce that AINOSTICS was selected as the winner of the connected health category at the 2020 Med-Tech...

AINOSTICS

AINOSTICS staff selected as regional leads for the DEMON Network

It is with great pleasure to announce that Dr Hamied Haroon and Dr Helen Beaumont, who are part of the Imaging Research and Development...

2/3